Seer Ranked Number 57 Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500™
22 November 2024 - 8:05AM
Seer, Inc. (Nasdaq: SEER), a leading life sciences company
commercializing a disruptive new platform for proteomics, today
announced it ranked No. 57 on the Deloitte Technology Fast 500™, a
ranking of the 500 fastest-growing technology, media,
telecommunications, life sciences, fintech, and energy tech
companies in North America, now in its 30th year. Seer grew 2,440%
during this period.
Seer’s President and CFO, David Horn, credits
increased adoption of Seer’s Proteograph Product Suite, as well as
new discoveries made by its customers across neurodegenerative
disease, cancer, and metabolic disease, with the company’s 2,440%
revenue growth.
"This has been an exciting year for Seer, from the
launch of our technology access center in Europe, to seeing our
Proteograph platform used by astronauts on the SpaceX Inspiration4
mission, to the recent announcement of our co-marketing and sales
agreement with Thermo Fisher Scientific,” Horn said. “We’re proud
to see continuing validation of our work providing customers and
the broader scientific community with the power to enable deep
proteomic insights at a scale and price point that hasn’t been
possible before."
Seer previously ranked No. 5 as a Technology Fast
500 award winner for 2023.
Overall, 2024 Technology Fast 500 companies
achieved revenue growth ranging from 201% to 153,625% over the
three-year time frame, with an average growth rate of 1,981% and
median growth rate of 460%.
About the 2024 Deloitte Technology Fast
500:
Now in its 30th year, the Deloitte Technology Fast
500 provides a ranking of the fastest-growing technology, media,
telecommunications, life sciences, fintech, and energy tech
companies — both public and private — in North America. Technology
Fast 500 award winners are selected based on percentage fiscal year
revenue growth from 2020 to 2023.
In order to be eligible for Technology Fast 500
recognition, companies must own proprietary intellectual property
or technology that is sold to customers in products that contribute
to a majority of the company’s operating revenues. Companies must
have base-year operating revenues of at least US$50,000, and
current-year operating revenues of at least US$5 million.
Additionally, companies must be in business for a minimum of four
years and be headquartered within North America.
About Seer:
Seer is a life sciences company developing
transformative products that open a new gateway to the proteome.
Seer’s Proteograph Product Suite is an integrated solution that
includes proprietary engineered nanoparticles, consumables,
automation instrumentation and software to perform deep, unbiased
proteomic analysis at scale in a matter of hours. Seer designed the
Proteograph workflow to be efficient and easy to use, leveraging
widely adopted laboratory instrumentation to provide a
decentralized solution that can be incorporated by nearly any lab.
Seer’s Proteograph Product Suite is for research use only and is
not intended for diagnostic procedures. For more information,
please visit www.seer.bio.
Media Contact: Patrick Schmidt
pr@seer.bio
Investor Contact: Carrie Mendivil
investor@seer.bio
About Deloitte:
Deloitte provides industry-leading audit,
consulting, tax and advisory services to many of the world’s most
admired brands, including nearly 90% of the Fortune 500® and more
than 8,500 U.S.-based private companies. At Deloitte, we strive to
live our purpose of making an impact that matters by creating trust
and confidence in a more equitable society. We leverage our unique
blend of business acumen, command of technology, and strategic
technology alliances to advise our clients across industries as
they build their future. Deloitte is proud to be part of the
largest global professional services network serving our clients in
the markets that are most important to them. Bringing more than 175
years of service, our network of member firms spans more than 150
countries and territories. Learn how Deloitte’s approximately
460,000 people worldwide connect for impact at
www.deloitte.com.
Deloitte refers to one or more of Deloitte Touche
Tohmatsu Limited, a UK private company limited by guarantee
(“DTTL”), its network of member firms, and their related entities.
DTTL and each of its member firms are legally separate and
independent entities. DTTL (also referred to as “Deloitte Global”)
does not provide services to clients. In the United States,
Deloitte refers to one or more of the US member firms of DTTL,
their related entities that operate using the “Deloitte” name in
the United States and their respective affiliates. Certain services
may not be available to attest clients under the rules and
regulations of public accounting. Please see
www.deloitte.com/about to learn more about our global network
of member firms.
Seer (NASDAQ:SEER)
Historical Stock Chart
From Nov 2024 to Dec 2024
Seer (NASDAQ:SEER)
Historical Stock Chart
From Dec 2023 to Dec 2024